ATLAS / Macro Radar / Reporting / GNLX

GENELUX Corp (GNLX) reporting calendar

GENELUX Corp files periodic reports with the SEC as GNLX on Nasdaq. Atlas tracks 14 filed reports for this issuer, each linked to its original EDGAR accession.

Next window
16 Jul 2026 – 4 Sep 2026
Latest report
10-Q
Period ended
31 Mar 2026
Filed
7 May 2026
Reports on record
14

How this window is derived. Derived from this issuer's own filing history: 9 periods at a median 91-day cadence, filed a median 41 days after period end. The SEC does not publish forward reporting dates and Atlas does not estimate one.

Open GNLX market profile Latest filing on SEC EDGAR ↗ Pharmaceutical Preparations reporting datesAll Nasdaq reporting dates

Filed periodic reports

FormPeriod endedFiledLagSEC accession
10-Q31 Mar 20267 May 202637 days0001493152-26-021710
10-K31 Dec 202519 Mar 202678 days0001493152-26-011616
10-Q30 Sep 20255 Nov 202536 days0001493152-25-020874
10-Q30 Jun 20257 Aug 202538 days0001641172-25-022583
10-Q31 Mar 20256 May 202536 days0001641172-25-008838
10-K31 Dec 202428 Mar 202587 days0001641172-25-001184
10-Q30 Sep 202414 Nov 202445 days0001493152-24-045790
10-Q30 Jun 202414 Aug 202445 days0001493152-24-032145
10-Q31 Mar 20249 May 202439 days0001493152-24-018436
10-K31 Dec 202329 Mar 202489 days0001493152-24-011946
10-Q30 Sep 202314 Nov 202345 days0001493152-23-041151
10-Q30 Jun 202314 Aug 202345 days0001493152-23-027998
10-Q31 Mar 202315 May 202345 days0001493152-23-016832
10-K31 Dec 202229 Mar 202388 days0001193125-23-083829

Source: SEC EDGAR company submissions for CIK 0001231457. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.